Opko Health, Array Biopharma, Abercrombie & Fitch News Today

Opko Health, Array Biopharma, Abercrombie & Fitch stocks are making big moves this morning

May 10, 2017 at 10:16 AM
facebook X logo linkedin


The surprise firing of FBI Director James Comey has put pressure on stocks this morning. Among specific stocks on the move are diagnostics firm Opko Health Inc. (NASDAQ:OPK), biotech Array Biopharma Inc (NASDAQ:ARRY), and retailer Abercrombie & Fitch Co. (NYSE:ANF). Here's a quick look at what's moving shares of OPK, ARRY, and ANF. 

OPK Stock Dives on Disappointing Revenue

Weak first-quarter sales are weighing on OPKO stock today, with the shares down 10.5% at $6.74, earlier touching a more than two-year low of $6.69 and landing on the short-sale restricted list. Opko Health has been falling fast on the charts, surrendering nearly half its value since topping out at $12.15 in mid-December, and bearish analyst notes seem overdue. At the moment, four of the five brokerage firms tracking OPKO shares say they're a "strong buy." 

ARRY Stock Takes Off After Results

Conversely, ARRY shares are soaring, up 26.7% at $8.90, thanks to the company's fiscal third-quarter earnings report and upbeat data on its COLUMBUS drug trial. Array said it intends to file a New Drug Application within the next few months, prompting Cantor Fitzgerald to reiterate an "overweight" rating and $13 price target. The stock is now back in positive year-to-date territory, and the move could be great news for ARRY options traders. Data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows a 10-day call/put volume ratio of 22.94 for Array Biopharma, meaning nearly 23 calls have been bought to open for each put during the past two weeks. 

Takeover Talk Gives ANF Stock a Lift

ANF stock is up 10.2% this morning at $13.96, after Reuters reported the company is interested in courting takeover bids from fellow retailers. The shares are on pace for their highest close since mid-December, but remain below their 200-day moving average, a trendline they haven't topped in almost one year. Today's news and price action is isn't what Abercrombie & Fitch short sellers want to see, since these bears control almost 30% of the stock's float. 
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI